share_log

Ensysce Biosciences Q4 EPS $(1.13) Misses $(0.87) Estimate, Sales $515.03K Beat $390.00K Estimate

Benzinga ·  Mar 15 08:06

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(1.13) per share which missed the analyst consensus estimate of $(0.87) by 29.89 percent. This is a 93.8 percent increase over losses of $(18.24) per share from the same period last year. The company reported quarterly sales of $515.03 thousand which beat the analyst consensus estimate of $390.00 thousand by 32.06 percent. This is a 64.06 percent decrease over sales of $1.43 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment